Dr. Asmita Rayamajhi, MD

Consultant Radiation & Medical Oncologist

Dr. Asmita is a distinguished oncologist recognized for her multidisciplinary expertise in the comprehensive management of cancer. Board-certified in both Radiation and Medical Oncology, she bridges the gap between different treatment modalities to provide holistic, patient-centered care.

Her international credentials from the Royal College of Radiologists (UK) and the European Society for Medical Oncology (ESMO) ensure that her clinical practice and editorial reviews align with the most rigorous global standards in oncology.

Education & International Certifications

- MD in Radiation Oncology: National Academy of Medical Sciences (NAMS), Bir Hospital, Nepal.
- COMR (UK): Certification from the Royal College of Radiologists, NHS, United Kingdom.
- European Certified Medical Oncologist: Recognition of expertise in medical oncology across the European Union.

Clinical Expertise & Multidisciplinary Care

Dr. Asmita’s practice is characterized by a "Total Care" approach, utilizing the full spectrum of modern cancer treatments:

Precision Radiation Therapy: Specialized in target-volume definition and dose optimization for tumor control.
Medical Oncology: Expert administration of Chemotherapy, Targeted Therapy, and Immunotherapy.
Screening & Early Detection: Specialized focus on enhancing cancer screening protocols among healthcare professionals.

Research & Scientific Contributions

As a dedicated researcher, Dr. Asmita contributes to the evolution of oncology through peer-reviewed studies. Her research focus includes:

Healthcare Professional Literacy: Analyzing and improving cancer screening practices within the medical community.
Molecular Oncology: Investigating the biological mechanisms of tumor progression to identify new therapeutic targets.
Clinical Trials: Evaluating the efficacy of emerging treatment combinations to improve patient survival and quality of life.

Medical Reviewer Disclaimer

The information reviewed by Dr. Asmita on TheHealth Thread is for educational purposes only and reflects current standards in oncology. Cancer treatment is highly individualized; this content does not replace the advice of an oncology multidisciplinary team (MDT).